British fertility researchers have developed an accurate way to predict which pregnancies are most likely to miscarry and say it could help target treatment at women who really need it.
In a study presented at European Society for Human Reproduction and Embryology conference in Stockholm this week, researchers found six factors with the greatest impact on miscarriage risk - a history of subfertility, levels of progesterone and of human chorionic gonadotropin (hCG), fetus length, the extent of bleeding, and the baby's gestational age.
Individually, these factors were unable to predict accurately the risk of miscarriage, but when the researchers combined two of them - bleeding and hCG levels - to create a "Pregnancy Viability Index," they found this was a consistently reliable predictor of miscarriage.
"This research has, for the first time, offered us a robust tool to begin to attempt to rescue pregnancies threatening to miscarry when currently all we can do is fold our hands and hope for the best," said Dr. Kaltum Adam of St Mary's Hospital, Manchester, who led the study.
Around 20% of all pregnancies threaten to miscarry and up to about 20% of those do.
Dr. Adam said the inability to predict which pregnancies will miscarry "has led to wasteful and potentially harmful interventions, including unnecessary blood tests, ultrasound scans, hospital admissions for bed rest, sexual abstinence, low dose aspirin and progesterone supplementation."
Between 2009 and 2010, Dr. Adam's team studied 112 women with threatened miscarriages who were between six and 10 weeks pregnant. During the five weeks of the study the women had ultrasound scans, weekly charting of pain and bleeding and weekly tests to check the levels of progesterone and hCG.
After analysing data on the outcomes of these pregnancies, Dr. Adam found there were six most important miscarriage factors, and from there the researchers developed their Pregnancy Viability Index, or PVI.
"The PVI was able to accurately predict the pregnancy outcome in 94% of women who had ongoing pregnancies, and also predicted the outcome in 77% of women whose pregnancy ended in miscarriage," Dr. Adam said in a statement.
She said the PVI could now enable doctors to avoid unnecessary treatment in around 80% of women with threatened miscarriage.
"The use of the PVI will negate these in the vast majority of these women, as we will be able to reassure them of a high likelihood of pregnancy continuation and that there is little additional value in doing further testing," Dr. Adam said.
She said the PVI would also allow doctors to focus on the remaining 20% of risky pregnancies that do go on to miscarry, hopefully giving them a better understanding of the what goes wrong and how they might be rescued.